Does OXCARBAZEPINE Cause Salivary hypersecretion? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Salivary hypersecretion have been filed in association with OXCARBAZEPINE (OXCARBAZEPINE). This represents 0.2% of all adverse event reports for OXCARBAZEPINE.
23
Reports of Salivary hypersecretion with OXCARBAZEPINE
0.2%
of all OXCARBAZEPINE reports
5
Deaths
10
Hospitalizations
How Dangerous Is Salivary hypersecretion From OXCARBAZEPINE?
Of the 23 reports, 5 (21.7%) resulted in death, 10 (43.5%) required hospitalization, and 6 (26.1%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OXCARBAZEPINE. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does OXCARBAZEPINE Cause?
Seizure (1,525)
Drug ineffective (1,498)
Off label use (751)
Hyponatraemia (708)
Somnolence (634)
Dizziness (558)
Fatigue (551)
Epilepsy (509)
Headache (505)
Asthenia (429)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
ARIPIPRAZOLE (497)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
Which OXCARBAZEPINE Alternatives Have Lower Salivary hypersecretion Risk?
OXCARBAZEPINE vs OXITRIPTAN
OXCARBAZEPINE vs OXOMEMAZINE
OXCARBAZEPINE vs OXY TAB
OXCARBAZEPINE vs OXYBATE
OXCARBAZEPINE vs OXYBUTYNIN